---
title: "ACTION PAC: Adolescents Committed to Improvement of Nutrition & Physical Activity"
nct_id: NCT02502383
overall_status: COMPLETED
phase: NA
sponsor: University of New Mexico
study_type: INTERVENTIONAL
primary_condition: Overweight
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02502383.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02502383"
ct_last_update_post_date: 2024-06-26
last_seen_at: "2026-05-12T06:19:59.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# ACTION PAC: Adolescents Committed to Improvement of Nutrition & Physical Activity

**NCT ID:** [NCT02502383](https://clinicaltrials.gov/study/NCT02502383)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 991
- **Lead Sponsor:** University of New Mexico
- **Conditions:** Overweight, Obesity
- **Start Date:** 2014-02-01
- **Completion Date:** 2017-11-29
- **CT.gov Last Update:** 2024-06-26

## Brief Summary

Using a previously created weight management program for adolescents, the intervention will be implemented through school-based health centers (SBHC) and will be delivered by SBHC providers trained in Motivational Interviewing. Students at intervention school sites will be compared to students at control school sites. All students will have baseline, 1 year, and 2 year follow-up to assess if students in the intervention school sites will have improved risk factor profile for metabolic syndrome, improved nutrition and increased physical activity when compared with students at control school sites.

## Eligibility

- **Minimum age:** 13 Years
- **Maximum age:** 20 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* enrolled in 9th or 10th grade at participating schools

Exclusion Criteria:

* blood pressure in the range of stage 2 hypertension
* previously diagnosed type 1 or type 2 diabetes
* use of corticosteroids, antipsychotics, metformin, antihypertensive medications, and medications used for dyslipidemia
* inability to perform moderate to vigorous physical activity
* not ambulatory
* a score of 20 or more on Eating Attitudes Test (EAT)-26 screening measure
* developmental disorders that affect weight or ability to understand the study procedures or counseling
```

## Arms

- **ACTION PAC Behavioral Intervention** (EXPERIMENTAL) — Students attending intervention schools will receive the ACTION PAC intervention and communication of BMI and other health results to parents via a letter.
- **Comparison** (ACTIVE_COMPARATOR) — Students attending comparison schools will receive communication of BMI and other health results to parents via a letter.

## Interventions

- **ACTION PAC** (BEHAVIORAL) — School-based health center providers will use motivational interviewing to assist students with adopting strategies for improving nutrition and increasing physical activity. All participants will receive annual BMI and other health results discussion with clinical providers. Adolescents with overweight/obesity will meet with providers for 16 sessions over 2 years.
- **Communication with parents** (BEHAVIORAL) — A letter containing BMI and other health results and obesity prevention recommendations will be sent to parent/guardians.

## Primary Outcomes

- **Number and Proportion of Participants With Baseline BMI <85th Percentile Who Developed Overweight or Obesity by the End of the Study** _(time frame: Baseline to two years)_ — Number and percentage of students who had a baseline BMI \<85th percentile who had a BMI\>= 85th percentile (overweight or obese) at endline
- **Change in Physical Activity** _(time frame: Baseline to two years)_ — Change in minutes of moderate-to-vigorous physical activity as measured by accelerometer for participants who had a baseline BMI \<85th percentile and endline data
- **Change in Reported Added Sugar Intake** _(time frame: Baseline to two years)_ — Reported change in added sugar intake as measured by the Block Kids Food Screener-Last Week for Ages 2-17 for students who had a baseline BMI \<85th percentile and endline data
- **Change in Reported Fruit, Vegetables, and Legume Intake (Not Including Potatoes)** _(time frame: Baseline to two years)_ — Change in reported fruit, vegetables, and legume intake (not including potatoes) for students who had a baseline BMI \<85th percentile and endline data
- **Change in BMI Z-score** _(time frame: Baseline to two years)_ — Change in body-mass index (BMI; weight in kilograms divided by the square of the body height in meters) Z-score for students who had a baseline BMI \>= 85th percentile (overweight or obese) and endline data. A Z-score of 0 represents the population mean. A Z-score above 2 indicates obesity (BMI \>2 standard deviations above the mean) in children and teens. A decline in BMI Z-score would be a positive outcome in this weight management study.
- **Change in HOMA-IR** _(time frame: Baseline to two years)_ — Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR; insulin resistance index) for students who had a baseline BMI \>= 85th percentile (overweight or obese) and endline data. HOMA-IR is calculated using the formula: (fasting glucose \[mg/dL\] x fasting insulin \[microU/mL\])/405. HOMA-IR values \>2 indicate insulin resistance. A decrease in HOMA-IR would be a positive outcome.

## Locations (1)

- Alberta S Kong, MD, MPH, Albuquerque, New Mexico, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.alberta s kong, md, mph|albuquerque|new mexico|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02502383.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02502383*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*